Bharat's statement said it will continue to work with Brazilian health care regulator Anvisa to obtain all required approvals for the use of Covaxin in the country
from Today's Paper https://ift.tt/3yeC7Kd
from Today's Paper https://ift.tt/3yeC7Kd
Comments
Post a Comment